The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...

Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones ...

Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...

UCLA researchers developed a human stem cell-derived cell therapy for an aggressive type of breast cancer. This study focused ...

High-dose vitamin B3 (niacin) may boost immune function and slow glioblastoma progression, with 82% of trial patients showing ...

Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used ...

Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

Millions of Americans take daily supplements-nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide ...